Carbon monoxide releasing molecules: new insights for anticoagulation strategy in sepsis

Area of Science:

• Critical care medicine
• Hematology
• Toxicology

Background:

• Sepsis is a life-threatening condition with high mortality, often complicated by coagulation abnormalities.
• Despite advances, effective sepsis treatments remain limited, highlighting the need for novel therapeutic strategies.
• Coagulation system dysregulation, from activation to disseminated intravascular coagulation (DIC), is a hallmark of sepsis.

Purpose of the Study:

• To investigate the potential role of carbon monoxide (CO) in mitigating sepsis-induced coagulation abnormalities.
• To explore whether CO administration can improve outcomes and decrease mortality in sepsis.
• To determine if CO's cytoprotective and anti-inflammatory properties extend to the management of sepsis-related coagulopathy.

Main Methods:

• Review of existing literature on sepsis, coagulation disorders, and carbon monoxide's physiological effects.
• Analysis of preclinical and clinical studies investigating CO in sepsis models.
• Examination of data on CO's impact on coagulation markers and patient survival.

Main Results:

• Carbon monoxide (CO) exhibits known cytoprotective and anti-inflammatory effects.
• Sepsis is consistently associated with significant coagulation system abnormalities, including DIC.
• The specific impact of CO on sepsis-induced coagulation dysfunction and mortality remains under investigation.

Conclusions:

• Carbon monoxide (CO) presents a potential therapeutic avenue for sepsis, particularly concerning its effects on coagulation.
• Further research is warranted to definitively establish CO's role in improving sepsis outcomes and reducing mortality.
• Investigating CO as a novel agent could open new therapeutic directions for managing sepsis and its associated complications.